https://vlree.xyz/session/check-in-morning-coffee/2026-09-09T09:06:10+00:00https://vlree.xyz/session/chairs-opening-remarks/2026-09-09T09:07:40+00:00https://vlree.xyz/session/current-cancer-vaccine-strategies-including-initial-phase-1-study-data-of-cvgbm-an-off-the-shelf-cancer-vaccine-in-glioblastoma/2026-09-09T09:31:40+00:00https://vlree.xyz/session/morning-break-speed-networking/2026-09-09T09:32:30+00:00https://vlree.xyz/session/the-value-of-a-harmonised-regulatory-framework-for-mrna-medicines/2026-09-09T09:33:04+00:00https://vlree.xyz/session/swiss-regulatory-aspects-evaluation-for-mrnabased-vaccines-therapeutic-pathways-to-approval/2026-09-09T09:33:51+00:00https://vlree.xyz/session/session-reserved-for-tebu-bio/2026-09-09T09:34:21+00:00https://vlree.xyz/session/lunch-break-networking/2026-09-09T09:37:55+00:00https://vlree.xyz/session/regerna-project-identifying-developing-mrnaencoded-proteins-towards-novel-therapeutics-for-cardiac-tissue-regeneration/2026-09-11T07:21:11+00:00https://vlree.xyz/session/multidimensional-characterisation-of-rna-based-vaccines-therapies/2026-09-11T07:22:49+00:00https://vlree.xyz/session/afternoon-break-poster-session/2026-09-11T07:23:13+00:00https://vlree.xyz/session/advancing-rna-therapeutics-development-novel-reagents-for-dna-template-production-by-rolling-circle-amplification/2026-09-11T07:23:44+00:00https://vlree.xyz/session/panel-discussion-a-european-industry-regulatory-perspective-on-the-development-approval-of-mrna-medicines/2026-09-11T07:24:36+00:00https://vlree.xyz/session/end-of-conference-day-one/2026-09-11T07:25:08+00:00https://vlree.xyz/session/end-of-conference-day-one-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/panel-discussion-a-european-industry-regulatory-perspective-on-the-development-approval-of-mrna-medicines-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/advancing-rna-therapeutics-development-novel-reagents-for-dna-template-production-by-rolling-circle-amplification-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/afternoon-break-poster-session-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/multidimensional-characterisation-of-rna-based-vaccines-therapies-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/regerna-project-identifying-developing-mrnaencoded-proteins-towards-novel-therapeutics-for-cardiac-tissue-regeneration-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/lunch-break-and-networking/2026-09-13T12:42:29+00:00https://vlree.xyz/session/session-reserved-for-tebu-bio-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/swiss-regulatory-aspects-evaluation-for-mrnabased-vaccines-therapeutic-pathways-to-approval-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/the-value-of-a-harmonised-regulatory-framework-for-mrna-medicines-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/morning-break-speed-networking-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/current-cancer-vaccine-strategies-including-initial-phase-1-study-data-of-cvgbm-an-off-the-shelf-cancer-vaccine-in-glioblastoma-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/chairs-opening-remarks-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/check-in-morning-coffee-2/2026-09-13T12:42:29+00:00https://vlree.xyz/session/lunch-break-and-networking-2/2026-09-15T07:24:28+00:00https://vlree.xyz/session/import-session-1/2026-09-25T00:45:31+00:00